IRIS
CHISARI, CLARA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.024
AS - Asia 3.195
EU - Europa 2.868
SA - Sud America 519
AF - Africa 515
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 12.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.873
SG - Singapore 1.620
RU - Federazione Russa 1.177
CN - Cina 824
IT - Italia 689
BR - Brasile 443
IE - Irlanda 339
CI - Costa d'Avorio 292
VN - Vietnam 268
KR - Corea 170
FR - Francia 145
UA - Ucraina 123
CA - Canada 104
DE - Germania 83
GB - Regno Unito 82
IN - India 69
NG - Nigeria 64
SN - Senegal 63
NL - Olanda 45
FI - Finlandia 38
SE - Svezia 37
ZA - Sudafrica 34
MX - Messico 33
TR - Turchia 32
PL - Polonia 30
BD - Bangladesh 29
IQ - Iraq 25
AR - Argentina 22
JP - Giappone 22
BJ - Benin 21
HK - Hong Kong 20
UZ - Uzbekistan 17
VE - Venezuela 17
CH - Svizzera 16
ES - Italia 16
PK - Pakistan 16
ID - Indonesia 11
AE - Emirati Arabi Uniti 10
EC - Ecuador 10
EG - Egitto 9
KE - Kenya 9
AT - Austria 8
CL - Cile 7
MA - Marocco 7
SA - Arabia Saudita 7
CO - Colombia 6
CZ - Repubblica Ceca 6
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
PE - Perù 6
PY - Paraguay 6
TN - Tunisia 6
BG - Bulgaria 5
HR - Croazia 5
IR - Iran 5
LT - Lituania 5
TH - Thailandia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
AU - Australia 3
ET - Etiopia 3
PH - Filippine 3
AL - Albania 2
AO - Angola 2
BE - Belgio 2
DM - Dominica 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 12.127
Salva come PNG Salva come JPEG
Città #
Singapore 1.006
Dallas 941
Santa Clara 679
Moscow 516
Chandler 445
Dublin 331
Ashburn 311
San Jose 306
Abidjan 291
Hefei 256
Chicago 229
Catania 168
Seoul 168
Boardman 138
Los Angeles 133
Lauterbourg 108
Jacksonville 106
Beijing 105
Council Bluffs 94
Civitanova Marche 90
Cambridge 80
Lawrence 79
Andover 76
Ho Chi Minh City 75
Dakar 63
Nanjing 60
Saint Petersburg 60
Hanoi 55
New York 54
Toronto 53
São Paulo 52
Des Moines 48
Buffalo 38
Lagos 33
Bremen 32
Milan 30
Orem 29
Abuja 26
Dong Ket 26
Denver 25
Warsaw 25
Houston 24
Wilmington 24
Johannesburg 23
Lappeenranta 23
San Francisco 23
Amsterdam 22
Rome 22
Cotonou 21
Tokyo 20
Hong Kong 19
London 18
Montreal 18
Columbus 17
Nanchang 17
Shenyang 17
Phoenix 16
Stockholm 16
The Dalles 16
Chennai 15
Palermo 15
Rio de Janeiro 15
Belo Horizonte 14
Brooklyn 13
Da Nang 13
Hebei 13
Poplar 13
Seattle 13
Manchester 12
Mascalucia 12
Mexico City 12
Munich 12
Naples 11
Ottawa 11
Redwood City 11
Ankara 10
Bernareggio 10
Haiphong 10
Helsinki 10
Kiev 10
Mumbai 10
San Mateo 10
Baghdad 9
Charlotte 9
Frankfurt am Main 9
Tashkent 9
Abu Dhabi 8
Atlanta 8
Boston 8
Brasília 8
Giarre 8
Istanbul 8
Porcari 8
Porto Alegre 8
Rende 8
Cape Town 7
Florence 7
Nairobi 7
Pune 7
Redondo Beach 7
Totale 8.214
Salva come PNG Salva come JPEG
Nome #
The ocular ecosystem in the discoid lupus erythematosus 231
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 174
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 168
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 167
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease 160
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 159
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 159
An update on the safety of treating relapsing-remitting multiple sclerosis 149
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 148
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 146
An update on the pharmacological management of pain in patients with multiple sclerosis 142
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 138
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 137
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 136
Amniotic membrane use in type 2 diabetes patients with chronic ulcers: Microbiological evaluation and therapeutic benefits 135
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 130
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 130
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 129
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 128
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 127
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 126
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 125
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 125
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 124
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 123
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 121
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 120
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 119
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 118
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 116
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 114
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 113
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 113
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 112
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 110
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 110
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 110
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 109
Etiology of chronic skin lesions in subjects with peripheral arterial disease 108
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 107
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 107
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 107
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 106
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 104
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 103
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 103
The Italian Multiple Sclerosis Register Experience With Cladribine 103
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 103
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 103
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 103
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 103
Palliative care in multiple sclerosis 102
Pharmacoeconomics of synthetic therapies for multiple sclerosis 102
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 101
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 100
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 100
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 99
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 96
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 95
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 93
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 93
Risk factors for ocular surface disorders in patients with type 2 diabetes 93
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols 93
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 92
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 92
A MACROSCALE MODELLING APPROACH FOR NONLINEAR ANALYSIS OF MASONRY ARCH BRIDGES 91
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 91
Optic Nerve Head and Retinal Changes in Idiopathic Intracranial Hypertension: Correlation with Short-Term Cerebrospinal Fluid Pressure Monitoring 90
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis 90
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 89
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 89
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 88
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 87
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 87
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 87
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 87
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) 86
Incidence of late onset multiple sclerosis in Italy: a population-based study 86
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 86
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 85
The ocular surface in patients video display terminal (VDT) 85
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 82
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 82
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 82
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 80
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 78
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 78
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis 77
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 77
Rituximab for the treatment of multiple sclerosis: a review 77
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 76
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 76
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 75
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 73
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 73
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 73
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 73
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 72
Evolution of the concept of vascular dementia 71
Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study 70
Totale 10.661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 19 34 41
2021/2022595 54 93 13 22 90 4 88 18 18 4 19 172
2022/20231.281 87 90 29 138 100 196 16 269 282 12 50 12
2023/2024708 34 155 41 32 27 159 11 56 8 12 109 64
2024/20252.725 61 376 137 148 499 399 120 60 222 270 219 214
2025/20266.128 393 590 983 438 984 1.273 638 191 284 354 0 0
Totale 12.353